Text size Al Bello / Getty Images Apple shares climbed to new highs on Monday, crossing the $ 1.7 trillion valuation level for the first time and approaching $ 400 a share, as two more analysts raised the company’s price targets ahead of quarterly earnings. June due July 30. Bullish …
Read More »Moderna’s action jumps when an analyst expects the FDA to approve its Covid-19 vaccine
Text size Maddie Meyer / Getty Images Moderna’s shares have risen 239% so far this year, and the biotech company, which has no approved medications, has a market capitalization of more than $ 24 billion. But in a note sent out Monday morning, Jefferies analyst Michael Yee writes that the …
Read More »US service sector recovers strongly in June
FILE PHOTO: An employee routinely sanitizes server trays at a reopened restaurant after restrictions to prevent the spread of coronavirus disease (COVID-19) are eased in Bloomfield Hills, Michigan, USA, 8 of June 2020. REUTERS / Emily Elconin / File Photo WASHINGTON (Reuters) – Activity in the US service industry rebounded …
Read More »Moderna’s stock falls due to the report of the delay in the Covid-19 vaccine trial
Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »Pfizer’s shares rise as the company reveals the timeline for the coronavirus vaccine.
Text size Daniel Acker / Bloomberg Shares of the large pharmaceutical company Pfizer continue to rise one day after the company revealed promising and detailed data on a trial of its experimental vaccine Covid-19. Analysts said the highly aggressive timeline the company outlined on Wednesday was exciting, but far from …
Read More »